
        <!DOCTYPE html>
    <html lang="ja">
    <style>
    body
    {
        color: black;
        background-color: white;
    }
    div{
        font-size: 14px;
    }
    span
    {
        font-size: 18px;
    }
    #grad1{
        background: linear-gradient(transparent 60%,#99e4f1 30%);
        font-size: 18px;
        font-weight: bold;
    }
    #grad2{
        background: linear-gradient(transparent 60%,#fda1a1 30%);
        font-size: 18px;
        font-weight: bold;
    }

    </style>

    <head>
        <meta charset="UTF-8">
        <title>103-208</title>
    </head>

    <body>
        <h1>
        <a href="./103_207.html" rel="external" title="prev">≪</a>
        103-208
        <a href="./103_209.html" rel="external" title="next">≫</a>
        </h1>
        <div class='problem'>
            <p>
                <span id="grad1">　問題文　</span>
            </p>
            <p>
                <p>78歳女性。高血圧症とパーキンソン病で処方1を服用していた。パーキンソン病症状のコントロールが困難になったため、新たに処方2が追加された。</p>
<p><img alt="" class="alignnone size-full wp-image-3219" height="193.89999999999998" loading="lazy" sizes="(max-width: 632px) 100vw, 632px" src="data:;base64,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" width="442.4"/></p>
<h4>問208</h4>
<p>本症例において処方2が追加された原因として、最も適切なのはどれか。1つ選べ。</p>
<ol><li>ウェアリング・オフ</li><li>ジスキネジア</li><li>悪性症候群</li><li>動悸</li><li>異常興奮</li></ol>
<h4>問209</h4>
<p>以下に示すA～Cはセレギリン、レボドパ又はカルビドパのいずれかである。これらの医薬品に関する記述のうち、正しいのはどれか。2つ選べ。</p>
<p><img alt="" class="alignnone size-full wp-image-3210" height="220.5" loading="lazy" sizes="(max-width: 502px) 100vw, 502px" src="data:;base64,iVBORw0KGgoAAAANSUhEUgAAAfYAAAE7CAMAAAAYQ1PkAAAA6lBMVEUjGRYlHBksIyEuJiQxKigyKykzLCs1Liw2Ly08NzZDPj5EQD9FQUFIRERMSUlPTExVU1NWVFRZV1daWFhdW1thYGBlZGRmZWVnZmZqaWlramptbGxubm5vb290c3N1dHR5eXmCgoKJiYmRkZGUlZWYmJidnp6foKCio6Olpqamp6esra21tra6u7u+vr/AwcHCw8PGx8fHyMjJysrLy8zQ0NHT09TU1NXW1tfc3d3e39/f4ODj5OTo6enq6+vr7Ozt7e3v8PDw8fH09PT09fX19vb29/f4+fn6+vr7+/v8/Pz9/f3+/v7///8AHQ9LAAAQrUlEQVR42u2d7YODOBHGxzcOleiKHlpf9tquWGWLtue1ShXUA/X0nP//3/EDFALlJWzpbgjP82m7u91t5pdMZkIyIYYWKIIJgB0CdgjYP0jnMxAtDnu2saznBJCWhX1nbZLshXYZMC0H+9HxzszMiWeF4LQQ7BfPKWGfnSdM8UvA3nTtO2uDKd547K/XQC7bJWVwhynebOyVTw8tL5O8/hG4jMWePFuvBf4G6NDxLgBmJPZsRy/5AE821u7mh9YGnt5A7KHlJWUQ10K4pS9Ac8d+fnLO9Zy973cgI7BXI1nO2fs8AjR77NW8PZirVfM/NHPsVZT+qvDwpYr2oVljp2MzZx8IAyzM8CZgz0ex+lMXD9hNwT7mGWs/dlE0i0TbT+OtILE6SL8gCNg/7GOEiTrxO7AfbFr5K6ItsM/pY9yJPbbtiJlTlw7AvhzsWzrkg14EwL4c7MKW/y+wG4W9UAv22veuvwfsZmD3fd/3/WHswvd93xfEHAnaAruxTt4tnHzq1+d2V1xnfWA3MqTbMzNzQH4NOwVMPrAbnsBFNkU17HF6wmg3F3u5XBM0IvmA7BjYTcH+r9pP/sqdi7PpSQhgnzN2SZklL/meqWtT1t5l3hKwG4KdNxv5vUQ/+kvrr51oHYgVsJuCPXHkwU5EHQM+sGmFud0Y7MzV09wNERGFvHgtAXs5uydERIT9WMvAvnuWB/sG0Bfi5J+KPbkWqC8IO3Pu5XdE9ATky8Ge77O1iJ6wwX5B2HceM4egvjDs/JwxO2ThoLSG2KfbOXurC4egrif2MWfbxmJ3Qo9wokJPJz/ibNtY7OF3sTinIfaCierx9fM3R+bf5+/8fFw4l3gmn6fWBHtVx0DpxKtn+aMqGCUbazeqqmG2oxeTK2do84S5LD03WG60+IUR5Q3ys/Mjqhrmf/tsbnEsfTYWZOXo6j/4KhWtUwsBj+XZecWqhtVMY2xxLK1q15Sjq3tg1iZ/lRCwVhFFpaph7Y+aWjlDs0pVAwPzhvOQ477h3F8Xp6UImpmVM7SrS9dTwqZ16PWGgG0/PPY57javbmJxLI2rUDbLjXbEcN0hYIcr6K5q2BXDmVccS8eas3JElQwh6QwBewLD9qqGWXfGZtxlBlpuES5HV1lheqD85G35wgFQeScStM6NIAbDfMMuM5hFPXmFYrMNaMNuObS+ZEFUHpL49dByrzRlnGef1ul6IEAeXUeV7FkOAZWCsK+YBdniiv0/w59p9IoBsL9hii9G11DKJedmx3Epl6CAfO4qaNXXteae1ul8/OfVek5GXRsROt5lTPVxQezasTp2uQ/OO60z6x64bGeNWU4VxAdaj8HOfHR+Vt5tMd876jQ/7HcZO6KSMQ9PBDGv6TAKO/NvyhWl+aZ1i77jVRBzaouR2KVscrZp3eKxs0/+SOxqD42AXWvsLOwx2JMqemxdMQD2mWA/0Ajsl2vGXuXuc7yjDtiZ16NGe5mx1x4ahcBuuKqMvXan0QXYDVf1GF96aDSrO+qA/S0WqDL26qtZ3VEH7G+zQJWxV1/NaL0W2N9qgSpjl+4idoDdeAtUGfvscndgv8MCVcY+t9wd2O+yQJWxXzznt8C+GAtUGfv+e/PJ3YH9XgtIW/vnk7sD+/0WkB7EziV3B/YpLCCt187jlCywT2OB0PKy8qsE2JdigSysJnv9t1MD+wMsoP92amD/6SP+qO7L88D+IL1qvZ0a2B+l7IV2/xu4SR7YP0Ydl0RNNMWHDOw66nol3JYfdbkzsGs41vMLIFOXDsC+HF3v8j2IANiXI2HLlngQ9u6b5IH9gxovs7jymRp7903ywK4DduH7vu8LYo4EiQhO3lS5hZNP/frc7opgqlt+gV3HkG7PzMwB+TXsFEx2yy+wa5vARTZFNexxmroY7ebqulwTNCL5KP8WsJs63jsWZyNXGN1uPIppC/UC9gnYl6aVCIQL7Itz/S65MbBDwA4BOwTsELBDwA4BOwTsELBDwA4B+/Q6CHEC9sWpOBQB7ItSSkR2CuwL055WLp2AfWFyaR8UV30C+2IUE6XRgr38QrEHtGJ2iyNwwL4gH1+wB/blKCKyhbCJUmBfkPzrMcc9sC9IgvZxHMfL9fKLxB4V3j0iioF9MdpeR7k71ZknYJ+DjxdF5haIFbBDwA4BOwTsELBDwA4BOwTsELBDwA4BOwTsELBDwA4BOwTsELBDwA4BO7DDBMAOATsE7BCwQ8AOATsE7BCwQ8AOATsE7BCwQ8AOATsE7BCwQ8AOATsE7MAOATsE7BCwQ8AOATsE7BCwQ8AOATsE7BCwQ8AOATsE7BCwQ8AOGYY93goSq4P0Yitd1kmCmZnFknpyGgjbFkH1QoiguqX6aorCMjPFfrBp5a+ItszM+/yFvV8y9tgl11/b5KbMHNnkbrcu2ZFR2GPbjpg5denAHNv2gZkPth0vGHtxR+2WfObUzl8EZKcmYd9S7t4PIihaysx+PvaXiX1fGCEVW2af1vl318V3DcEubPkF5a4sqpq0POxrOskWKV6cSpO8F/bLSzLuDcmIN9Q+PFHzC6ardCKT7Y4j3xG+qg8EarNI9ZW4WuSh2LON9WztRtmEnukluxv7nshnJuH7vu9rNdqPjud4lxFvOD85T875buyxSyJmQb7v+77/UOw7a5Pw2XOUu3foeBdOni3F7u0WTj71g7qTj2m9pYOGTv7iOSFnO2uj2rNzY7xaz2o+cHv164HfcPIrEdjuezj5s/N0rmCqvOHaQcp3DjYyT9YC8ush3Z5SJl877NnG2mUVTCXnl7u+7IV2Kj1lX8SzEYlGSEcBb+nx2BPPCqtPr9C9k400Hah076+uCVxkU1RP4NITn2ivG/adtUkk131Wc34t9uzUf4sELnUpaCRwp5Rd8Wjszd453L0bPWO4e4ff/7Jcrglulmti29Uskm+6sNDyEjXn1/EHWkba78rlmi3fLNds6fRg7OVgzXavSt376HjnHnfRGuicuXtxNhZuqhX2qjXn56zhwTsnhD530TUh3CzO2sXi7JYOj03gKsK1Wb27e188J1TrC6rOw3VTrZK20nfVPnlPz24nXAYHLc5vwHns5Yy+LSu6t1+XDWt6qY7u3dOWjsYPhgoH2gZBpA31EsnNJ+9w3N0d/tKeFw2HCuQGwf5h2Cu0bV6qrXv3Rm9tXUIhMfCJqFyQ/PBJvd35dTe/w/l1N18hMYiHlq1okn7dNQ81u/dgnNLs3mOWAXRQt/PrCF4Hg9mmyxizDPAQ7FXDur1UrXsrZSVy925zITqr3/m1jW6V1LWW64bjFv0mx159mH4vVXbn/lC2rTv3hrIaqkLS/8nLUaK6UFVOHJepnN9bsZdshlPuvFsMJq5NT9njQrSUkvOTg1cl5ydPpz3R8PtgrxqmtH58dH7yA2cMw/OT0+tCNPTvpfNTopltrF+oP4TKfeXzhM7vbdi9nWKIdtWvnkf+hx9/+288q7HuqDq/6xtoJMM/f2PCZOWN2M+KmUTp1UaGZgn98CmbFXZP3fm9zfKbTynUAftRzUslyRuwv2xCepofdtUQ7Q2Wz6zMoYsG2JNEfaDvxidiDm1mh/04wujjLR+Sdfl47GP8+0jsXsj8SnPiXjj5h2E/O8yZNRl3LbGfrYw5s4hegV0OondEE0U8WmJ/2XHeyAmDmHljT6yMmTOairuO2K9PqGlG3B+MvTDJhmiaSFdH7N6xauRkQcyssR+frnktTRPxaIj96LDUyJlwfyz2csVyMxF3DbFvSsf+TERkZYvHfikd+5mIpoh09cMuUc4bOYvluodilwzg0SQRj37Y5UeLeSOf/rls7KH0QONIk3DXDnsoR6ohERF99u9FY89qDy8dIqJPvjAN+6b2px2iTz5f+Nx+qT29DInos7vdn27Y/9EY+xM0cebYv26YxJpiHGg32r+uv/yCeeHYm/rDFONAE+y9J1qK40+CuO+gx7yxt7SrduKFG7+9breCbKo+m84Du1gg9lo5ohvseUGXFuzCHOw2+cvDLpcjusVui3bskqlmj124dro07LVyRLfYA/JbsUummj/2E22Xhn3dd3hRELt23Iq9MtUcsPeVGyLBa4qu2Luq8Mwde6Ndvee1BfGB1jlZkm0nm6rPptqM9p5yQyQ4ovUVe1WFZ6/PgccJsFftCsiOBrHzuirX024q2aZNU83DyTP7dGg6+aJSkXFOPqatEPVyRG3YU1u0Yi9NJdn0xlT3bJhWOwcQhlNgT223ib2oVKQT9o3acPB6se8p9alejqgNO/vkt2K/mkqy6Y2p7tkwPeIM193Y2Se7gb2oVKQT9jGHNTuxpzGvBNfKEbViZ2G3Yr+aSrLpjanucvLqpxPvx86CbiL52HY1m9tHnE7sieRt8rlejqgV+4HasRemqtm0Yao3YQ+/9anSid7KKM792IMb7HmlIi2UfPrNYsuL4lnkbGN1Y48DOgwszhZJnugxlWzTpqnoLR3b+X3t/P5Q9x4zG4yRNpWKsh29/LG3eElTfWfl3IAnj1maphqNvShnUB17HOreymdAx0qbSkUF5+5SRbfOr++s3MoOtgOFpu421dgDeFWLzmrde0Q5g5HSpFJRVc5AKkzWV31lyPnFK7KDB5tqHPZjDbBC9z4/ObMqSTF+Uq8BlsoQdjVctZbLYzUG+02Rmo66e5UV1A/Az1Q3/b3y3+1ubhrnd/eTCXXsrcFbX/eeppSWzmpNYKVSrDfjeirn937Yu2LPzu49USktfdVVoasaHw1vN53zey/sfbFnmbtnO9rdBjqGqi9zrTrE2XlKHuD8psVeXzSpSjj/vT/2lLr3ufqOEXDr9pXu1xsoUlPFvsdHOL8HYpcKtn8+lHg3/N3c6ggq2lcu2P7Ls3Km+wDnd/eug07sLffrKaZ2c6sjqIq95X49xdRucufXfffPvdhb7tdT6t6XmdURVMfecr+e2kLO9M7vcU6+5X49he79sJVYDbC33K83pNDykkc4v4mxy7uybu/XU+je9JwwG4W9mkRb7tdT8IH0iMdQU4/2avfVW7Cbdx28PIm+BTszZaw/9nucvJnY73Lyj7LI47CPDenMxz46pNPYIlMlcAvAPjKBmyf2+v16wM7N+/UMxS7frwfsgrl+v55B2LX7cwYI2IEd2IEd2IEd2IEd2IEd2IEd2IEd2IEd2IEd2IEd2IEd2IEd2IEd2IF9pP4EzrOwCIYnfBAE7OMl7cLStRD0O0s6Ittfg23G2OU9l8DO3NhzaSj22g5rYOfmDmtDsdfOUwA7N89TGIq9dnoK2Ll5espQ7LWzkrpe8vC+tq2dley9IMMY7HeWWzAQe98FGXDycPII6RDSIYFDAqchdizX3GgJyzVYnG0Z79IRWWOxQ/NJMmACYIeAHQJ2CNghYIeAHQJ2CNghYIeAHQJ2yDjsQgghhL06weySDmshxDYyGPt1EyG4l0pXhU0Cg7Gf4jiOXHKB+yqXxCGOozXRwVzsETPzYeF7L2QFJPIy5f77joUPwY7RXg324paGNNibi71w8nvwzhUTpR/yjz8ipAvAu1D0UfPd+2K3hRA2iQjAF4U9YubUR0hXpm9E17t4DqZH8qlNMYg3QroT2aZjJ2C/ak8it8WKVmZH8vEaTl4e7mIfx6fVOy9dfsji7AG4y9ndNX9xtngUg0C+5udXttmPYiBtBOzADgE7BOwQsEPADgE7NBP9H6QwrVWswgPWAAAAAElFTkSuQmCC" width="351.4"/></p>
<ol><li>AとCは、同じ標的分子の別の部位に結合することにより、代謝反応によるドパミンの分解を阻害する。</li><li>Bは、生体内でドパミンに変化することによって活性を発現するプロドラッグである。</li><li>Bは、脳内で芳香族L-アミノ酸脱炭酸酵素による代謝を受ける。</li><li>Cは、一置換ヒドラゾン構造をもつ。</li><li>Cは、Bと同様に血液脳関門を通過しやすい。</li></ol>    
            </p>
        </div>
        <hr>

        <input type="button" value="check ans" onclick="toggle_switch()"/>
        
        <div id='toggle'>
        <div class='answer'>
            <p>
                <span id="grad2">　解答　　</span>
            </p>
            <p>
            問208：1問209：2, 3
            </p>
        </div>
        <div class='description'>
            <p>
                <span id="grad2">　解説　　</span>
            </p>
            <h4>問208</h4>
<p><span style="font-weight: 400;">選択肢 1 は、正しい記述です。<br/></span><span style="font-weight: 400;">ウェアリング・オフとは、</span><span style="font-weight: 400;">薬が効かない時間が出てくる現象のことです。</span><span style="font-weight: 400;">レボドパ治療継続に伴い現れてくる現象です。</span><span style="font-weight: 400;">COMT 阻害薬、MAO-B 阻害薬、</span><span style="font-weight: 400;">ゾニサミド、アデノシン A<sub>2A</sub></span><span style="font-weight: 400;"> </span><span style="font-weight: 400;">受容体拮抗薬</span><span style="font-weight: 400;">などで対応します。</span></p>
<p><span style="font-weight: 400;">選択肢 2 ですが<br/></span><span style="font-weight: 400;">ジスキネジアとは、</span><span style="font-weight: 400;">意思に反して手足が勝手に動いたりする</span><span style="font-weight: 400;">現象のことです。</span></p>
<p><span style="font-weight: 400;">選択肢 3 ですが<br/></span><span style="font-weight: 400;">悪性症候群とは、</span><span style="font-weight: 400;">発熱、意識障害などを伴う</span><span style="font-weight: 400;">抗ドパミン薬における</span><span style="font-weight: 400;">代表的副作用の一つです。</span></p>
<p><span style="font-weight: 400;">動悸、異常興奮については</span><span style="font-weight: 400;">特に追加する記述はありません。</span></p>
<p><span style="font-weight: 400;">以上より、</span><span style="font-weight: 400;">問208 の正解は 1 です。</span></p>
<h4>問209</h4>
<p><span style="font-weight: 400;">A はセレギリンです。</span><span style="font-weight: 400;">B はレボドパです。</span><span style="font-weight: 400;">C はカルビドパです。</span></p>
<p><span style="font-weight: 400;">選択肢 1 ですが<br/></span><span style="font-weight: 400;">A のセレギリンは、</span><span style="font-weight: 400;">MAOー</span><span style="font-weight: 400;">B</span><span style="font-weight: 400;">（</span><span style="font-weight: 400;">monoamine oxidases B）</span><span style="font-weight: 400;">阻害薬です。</span><span style="font-weight: 400;">C のカルビドパは</span><span style="font-weight: 400;">脱炭酸酵素阻害剤です。</span><span style="font-weight: 400;">従って</span><span style="font-weight: 400;">標的分子は同じではありません。</span><span style="font-weight: 400;">よって、選択肢 1 は誤りです。</span></p>
<p><span style="font-weight: 400;">選択肢 2,3 は、正しい記述です。</span></p>
<p><span style="font-weight: 400;">選択肢 4 ですが<br/></span><span style="font-weight: 400;">ヒドラ「ゾン」ではなく、ヒドラジンです。</span><span style="font-weight: 400;">よって、選択肢 4 は誤りです。</span><span style="font-weight: 400;">ちなみにヒドラゾン構造は</span><span style="font-weight: 400;">（R<sub>2</sub></span><span style="font-weight: 400;">）ーC＝NーNー（R<sub>2</sub></span><span style="font-weight: 400;">）　という構造です。</span></p>
<p><span style="font-weight: 400;">選択肢 5 ですが<br/></span><span style="font-weight: 400;">カルビドパは、</span><span style="font-weight: 400;">BBB（血液脳関門）を非通過です。</span><span style="font-weight: 400;">よって、選択肢 5 は誤りです。</span></p>
<p><span style="font-weight: 400;">以上より、正解は 2,3 です。</span></p>
            </p>
        </div>
        </div>
    </body>
    <script>
    document.getElementById("toggle").style.display="none";
    function toggle_switch(){
        var x = document.getElementById("toggle");
        if (x.style.display=="block"){
            x.style.display="none";
        }
        else{
            x.style.display="block";
        }
    }
    </script>
    